Coronavirus News
View More-
Sanofi and Translate Bio Initiate Phase 1/2 Clinical Trial of mRNA COVID-19 Vaccine Candidate
-
EUREKA THERAPEUTICS ANNOUNCES SUCCESSFUL PRECLINICAL RESULTS OF INVISIMASKTM HUMAN ANTIBODY NASAL SPRAY AGAINST SARS-COV-2 INFECTION
-
Merck to Acquire OncoImmune
-
ImmunityBio Gets FDA Authorisation to Begin Trial of Novel Covid-19 Vaccine Candidate
-
Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test
Technical Solutions
DRUG DEVELOPMENT
DNA Encoded Compound Library
In recent years, the biopharmaceutical industry has been undergoing some fundamental changes and transformation. These changes are underlined by the unwavering demands for great medicines to treat serious illness in both developed and developing countries, which highlight the urgent need for the biopharmaceutical industry to foster greater innovation, and to focus on developing various drug candidates.
DEL-
DRUG DEVELOPMENT
ADC
Artificial Intelligence plays a pivotal role in drug discovery. In particular, artificial neural networks, such as deep neural networks (DNN) or recurrent neural networks (RNN) drive the evolution of this area.
ADC -
DRUG DEVELOPMENT
Artificial Intelligence
Artificial Intelligence plays a pivotal role in drug discovery. In particular, artificial neural networks, such as deep neural networks (DNN) or recurrent neural networks (RNN) drive the evolution of this area.
AI -
DRUG DEVELOPMENT
Drug Repositioning
Drug reuse (also called drug rediscovery or drug relocation) refers to rediscovery of new indications for existing drugs. One of the most famous examples is sildenafil, whose purpose is to treat angina pectoris, and later found that it can also treat erectile dysfunction.
Drug Reposition -
DRUG DEVELOPMENT
Microfluidics
Microfluidics refers to the science and technology that use micropipes (tens to hundreds of microns in size) to process or manipulate tiny fluids.
Microfluidics
Latest Deals
View More- Thermo Fisher Scientific Acquires Novasep's Henogen Expanded Global Capacity Addresses Growing Demand for Cell and Gene Therapy
- Sanofi to Acquire Kymab, Adding KY1005 to Its Pipeline, a Human Monoclonal Antibody Targeting Key Immune System Regulator OX40L
- Novartis Builds on Commitment to Addressing Need in Neuropsychiatric Disorders with Cadent Therapeutics Acquisition
- Lilly Announces Agreement to Acquire Prevail Therapeutics
Latest News
Pfizer Acquires Amplyx Pharmaceuticals
04/28/2021
Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems.
Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001™ for Transfusion-Dependent Beta Thalassemia
04/26/2021
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to CTX001, an investigational, autologous, ex vivo CRISPR/Cas9 gene-edited therapy for the treatment of transfusion-dependent beta thalassemia (TDT).
Janux Therapeutics Closes $125 Million Series B Financing to Advance Next Generation T Cell Engager Immunotherapies into Clinical Trials
04/20/2021
Janux Therapeutics today announced the closing of a $125 million Series B financing led by RA Capital Management and joined by new investors BVF Partners L.P., EcoR1 Capital, Hartford HealthCare Endowment, Janus Henderson Investors, Logos Capital, Samsara BioCapital and Surveyor Capital (a Citadel company).
StrideBio Announces Closing of $81.5M Series B Financing
03/16/2021
StrideBio, Inc., a leading developer of novel engineered adeno-associated virus (AAV) based gene therapies, today announced the closing of an oversubscribed Series B funding round, which raised $81.5 million.
Sanofi and Translate Bio Initiate Phase 1/2 Clinical Trial of mRNA COVID-19 Vaccine Candidate
03/12/2021
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio (NASDAQ: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company, today announced the start of the Phase 1/2 clinical trial for MRT5500, an mRNA vaccine candidate against SARS-CoV-2, the virus that causes COVID-19.
Mount Sinai and Harbour BioMed collaborate to advance novel biotherapies to treat cancer and coronavirus COVID-19
12/22/2020
Mount Sinai Health System and Harbour BioMed (HBM) have entered into a multi-year, multifaceted collaboration to develop novel, fully human antibodies for the treatment and prevention of various diseases including oncology and immunology. The collaboration will...
EC approves Alnylam’s Givlaari for acute hepatic porphyria
12/22/2020
The European Commission (EC) has approved Alnylam’s Givlaari (givosiran) for adults and adolescents with acute hepatic porphyria (AHP). Givlaari was previously granted priority medicines designation by the European Medicines Agency, as well as orphan designatio...
Novartis, DNDi to jointly develop LXE408 for visceral leishmaniasis
12/22/2020
Novartis has signed a collaboration and licence agreement with the Drugs for Neglected Diseases initiative (DNDi) for the joint development of LXE408 as a new oral drug for the treatment of visceral leishmaniasis. LXE408 was discovered at Novartis with the fina...
Innovation plans to develop defensin mimetic for Covid-19 treatment
12/22/2020
Innovation Pharmaceuticals has announced the consideration of its defensin mimetic drug candidate Brilacidin for the potential treatment of Covid-19, the disease caused by the coronavirus. The company is in discussions with organisations and researchers to expl...
J&J partners HHS to speed-up coronavirus vaccine development
12/22/2020
Johnson & Johnson (J&J) unit Janssen Pharmaceutical has partnered with the US Department of Health & Human Services (HHS) to speed-up the development of its investigational vaccine candidate against the new coronavirus disease, Covid-19. The company and HHS’ Bi...
Featured Sponsors
